Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cardiac Allografts Market by Type (With Pulmonary Valve Lobe, Non Pulmonary Valve Lobe), By Application (Hospital, Clinic, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cardiac Allografts Market by Type (With Pulmonary Valve Lobe, Non Pulmonary Valve Lobe), By Application (Hospital, Clinic, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 299391 4200 Medical Devices & Consumables 377 211 Pages 4.8 (39)
                                          

Market Overview:


The global cardiac allografts market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cardiovascular diseases, increasing number of organ transplantations, and technological advancements in cardiac allografts. Based on type, the global cardiac allografts market is segmented into pulmonary valve lobe and non-pulmonary valve lobe. The pulmonary valve lobe segment is expected to grow at a higher CAGR during the forecast period owing to its advantages over other types of valves available in the market. Based on application, the global cardiac allografts market is segmented into hospitals, clinics, and other applications. The hospitals segment accounted for the largest share of the global cardiac allografts market in 2017 and is projected to grow at a higher CAGR during the forecast period.


Global Cardiac Allografts Industry Outlook


Product Definition:


A cardiac allograft is a human heart that has been transplanted into another person. The importance of cardiac allografts is that they can save the lives of people who have end-stage heart failure.


With Pulmonary Valve Lobe:


The pulmonary valve lobes are the structures that remain after the removal of a lung. They are used in cardiac allografts to help re-vascularize and re-pulmonaryize the organ. The growth factor for this market is increasing adoption of these devices as they have minimal side effects, high efficiency rate, and low risk of rejection.


Non Pulmonary Valve Lobe:


The non-pulmonary valve is a structure that helps in maintaining the pulmonary blood flow. It also prevents the backflow of blood from entering into the heart. The main function of this valve is to prevent regurgitation or inhaling air while lungs are inflated during expiration. This device is used as a part of cardiac allografts and consists of two valves, which are attached to either side of the heart via veins.


Application Insights:


Based on application, the global cardiac allografts market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a large patient base with multiple diseases that require heart transplantation as a treatment option. Furthermore, increasing number of hospitals offering cardiac transplantation services across the globe is also expected to contribute significantly towards revenue generation over the forecast period.


The other application segment includes private clinics and non-governmental organizations (NGOs). Cardiac allografts are used extensively by these institutions owing to their low cost compared to manufactured products such as bioprosthetic valves or artificial hearts which are used for similar purposes.


Regional Analysis:


North America dominated the global market in 2017 owing to a rise in the number of cardiac transplantation procedures and high acceptance of CABG surgeries. The U.S.


Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as increasing awareness about organ donation, growing medical tourism industry, improvement in healthcare infrastructure along with rising disposable income especially after economic reforms undertaken by various governments since 1990s.


Growth Factors:


  • Increasing incidence of cardiovascular diseases (CVDs)
  • Growing awareness about the benefits of cardiac allografts surgery
  • Rising number of organ transplantations due to the increasing prevalence of organ failure
  • Technological advancements in cardiac allograft surgery procedures
  • Increasing healthcare expenditure

Scope Of The Report

Report Attributes

Report Details

Report Title

Cardiac Allografts Market Research Report

By Type

With Pulmonary Valve Lobe, Non Pulmonary Valve Lobe

By Application

Hospital, Clinic, Other

By Companies

CryoLife, Inc., LeMaitre Vascular, CareDx, LifeNet Health, Medtronic

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

211

Number of Tables & Figures

148

Customization Available

Yes, the report can be customized as per your need.


Global Cardiac Allografts Market Report Segments:

The global Cardiac Allografts market is segmented on the basis of:

Types

With Pulmonary Valve Lobe, Non Pulmonary Valve Lobe

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. CryoLife, Inc.
  2. LeMaitre Vascular
  3. CareDx
  4. LifeNet Health
  5. Medtronic

Global Cardiac Allografts Market Overview


Highlights of The Cardiac Allografts Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. With Pulmonary Valve Lobe
    2. Non Pulmonary Valve Lobe
  1. By Application:

    1. Hospital
    2. Clinic
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cardiac Allografts Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cardiac Allografts Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Cardiac allografts are a type of transplant that involves the use of a donor heart. A donated heart is removed from a deceased person and then cleaned and prepared for transplant. The donor heart is then placed into a recipient who has been prepped with antibiotics to prevent infection.

Some of the major players in the cardiac allografts market are CryoLife, Inc., LeMaitre Vascular, CareDx, LifeNet Health, Medtronic.

The cardiac allografts market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Allografts Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Cardiac Allografts Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Cardiac Allografts Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Cardiac Allografts Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Cardiac Allografts Market Size & Forecast, 2018-2028       4.5.1 Cardiac Allografts Market Size and Y-o-Y Growth       4.5.2 Cardiac Allografts Market Absolute $ Opportunity

Chapter 5 Global Cardiac Allografts Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Cardiac Allografts Market Size Forecast by Type
      5.2.1 With Pulmonary Valve Lobe
      5.2.2 Non Pulmonary Valve Lobe
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Cardiac Allografts Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Cardiac Allografts Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Clinic
      6.2.3 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Cardiac Allografts Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Cardiac Allografts Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Cardiac Allografts Analysis and Forecast
   9.1 Introduction
   9.2 North America Cardiac Allografts Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Cardiac Allografts Market Size Forecast by Type
      9.6.1 With Pulmonary Valve Lobe
      9.6.2 Non Pulmonary Valve Lobe
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Cardiac Allografts Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Clinic
      9.10.3 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Cardiac Allografts Analysis and Forecast
   10.1 Introduction
   10.2 Europe Cardiac Allografts Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Cardiac Allografts Market Size Forecast by Type
      10.6.1 With Pulmonary Valve Lobe
      10.6.2 Non Pulmonary Valve Lobe
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Cardiac Allografts Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Clinic
      10.10.3 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Cardiac Allografts Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Cardiac Allografts Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Cardiac Allografts Market Size Forecast by Type
      11.6.1 With Pulmonary Valve Lobe
      11.6.2 Non Pulmonary Valve Lobe
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Cardiac Allografts Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Clinic
      11.10.3 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Cardiac Allografts Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Cardiac Allografts Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Cardiac Allografts Market Size Forecast by Type
      12.6.1 With Pulmonary Valve Lobe
      12.6.2 Non Pulmonary Valve Lobe
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Cardiac Allografts Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Clinic
      12.10.3 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Cardiac Allografts Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Cardiac Allografts Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Cardiac Allografts Market Size Forecast by Type
      13.6.1 With Pulmonary Valve Lobe
      13.6.2 Non Pulmonary Valve Lobe
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Cardiac Allografts Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Clinic
      13.10.3 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Cardiac Allografts Market: Competitive Dashboard
   14.2 Global Cardiac Allografts Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details â€“ Overview, Financials, Developments, Strategy) 
      14.3.1 CryoLife, Inc.
      14.3.2 LeMaitre Vascular
      14.3.3 CareDx
      14.3.4 LifeNet Health
      14.3.5 Medtronic

Our Trusted Clients

Contact Us